vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Orange County Bancorp, Inc. (OBT). Click either name above to swap in a different company.
Orange County Bancorp, Inc. is the larger business by last-quarter revenue ($33.0M vs $21.2M, roughly 1.6× Autolus Therapeutics plc). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs -373.3%, a 410.9% gap on every dollar of revenue. Orange County Bancorp, Inc. produced more free cash flow last quarter ($41.3M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.
AUTL vs OBT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $33.0M |
| Net Profit | $-79.1M | $12.4M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | 41.4% |
| Net Margin | -373.3% | 37.6% |
| Revenue YoY | — | 20.6% |
| Net Profit YoY | 3.6% | 73.5% |
| EPS (diluted) | $-0.30 | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $33.0M | ||
| Q3 25 | $21.2M | $33.7M | ||
| Q2 25 | $20.9M | $32.5M | ||
| Q1 25 | $9.0M | $28.0M | ||
| Q4 24 | — | $27.4M | ||
| Q3 24 | $0 | $27.1M | ||
| Q2 24 | $0 | $27.9M | ||
| Q1 24 | $10.1M | $25.3M |
| Q4 25 | — | $12.4M | ||
| Q3 25 | $-79.1M | $10.0M | ||
| Q2 25 | $-47.9M | $10.5M | ||
| Q1 25 | $-70.2M | $8.7M | ||
| Q4 24 | — | $7.2M | ||
| Q3 24 | $-82.1M | $3.2M | ||
| Q2 24 | $-58.3M | $8.2M | ||
| Q1 24 | $-52.7M | $9.3M |
| Q4 25 | — | 41.4% | ||
| Q3 25 | -337.9% | 38.6% | ||
| Q2 25 | -292.6% | 41.9% | ||
| Q1 25 | -726.3% | 40.3% | ||
| Q4 24 | — | 32.8% | ||
| Q3 24 | — | 14.8% | ||
| Q2 24 | — | 36.6% | ||
| Q1 24 | -384.1% | 45.9% |
| Q4 25 | — | 37.6% | ||
| Q3 25 | -373.3% | 29.7% | ||
| Q2 25 | -229.0% | 32.2% | ||
| Q1 25 | -781.1% | 31.1% | ||
| Q4 24 | — | 26.2% | ||
| Q3 24 | — | 11.8% | ||
| Q2 24 | — | 29.4% | ||
| Q1 24 | -522.1% | 36.7% |
| Q4 25 | — | $0.94 | ||
| Q3 25 | $-0.30 | $0.75 | ||
| Q2 25 | $-0.18 | $0.87 | ||
| Q1 25 | $-0.26 | $0.77 | ||
| Q4 24 | — | $0.64 | ||
| Q3 24 | $-0.31 | $0.28 | ||
| Q2 24 | $-0.22 | $0.73 | ||
| Q1 24 | $-0.24 | $0.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $284.4M |
| Total Assets | $661.9M | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $86.1M | — | ||
| Q2 25 | $123.8M | — | ||
| Q1 25 | $95.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $657.1M | — | ||
| Q2 24 | $705.9M | — | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $284.4M | ||
| Q3 25 | $265.5M | $270.1M | ||
| Q2 25 | $346.5M | $252.6M | ||
| Q1 25 | $371.1M | $201.3M | ||
| Q4 24 | — | $185.5M | ||
| Q3 24 | $477.0M | $193.1M | ||
| Q2 24 | $527.8M | $177.5M | ||
| Q1 24 | $582.0M | $168.7M |
| Q4 25 | — | $2.7B | ||
| Q3 25 | $661.9M | $2.6B | ||
| Q2 25 | $721.0M | $2.6B | ||
| Q1 25 | $746.3M | $2.6B | ||
| Q4 24 | — | $2.5B | ||
| Q3 24 | $827.5M | $2.5B | ||
| Q2 24 | $853.6M | $2.5B | ||
| Q1 24 | $901.4M | $2.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $43.8M |
| Free Cash FlowOCF − Capex | $-72.3M | $41.3M |
| FCF MarginFCF / Revenue | -341.2% | 125.1% |
| Capex IntensityCapex / Revenue | 20.8% | 7.6% |
| Cash ConversionOCF / Net Profit | — | 3.53× |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $69.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $43.8M | ||
| Q3 25 | $-67.9M | $30.2M | ||
| Q2 25 | $-72.8M | $-5.0M | ||
| Q1 25 | $-75.6M | $4.8M | ||
| Q4 24 | — | $34.6M | ||
| Q3 24 | $-76.7M | $10.2M | ||
| Q2 24 | $-51.1M | $9.3M | ||
| Q1 24 | $-40.5M | $2.3M |
| Q4 25 | — | $41.3M | ||
| Q3 25 | $-72.3M | $29.6M | ||
| Q2 25 | $-80.1M | $-5.7M | ||
| Q1 25 | $-83.8M | $4.3M | ||
| Q4 24 | — | $32.9M | ||
| Q3 24 | $-86.3M | $10.0M | ||
| Q2 24 | $-51.9M | $9.2M | ||
| Q1 24 | $-41.0M | $2.0M |
| Q4 25 | — | 125.1% | ||
| Q3 25 | -341.2% | 87.8% | ||
| Q2 25 | -382.6% | -17.5% | ||
| Q1 25 | -933.1% | 15.5% | ||
| Q4 24 | — | 120.0% | ||
| Q3 24 | — | 36.7% | ||
| Q2 24 | — | 32.8% | ||
| Q1 24 | -406.8% | 7.9% |
| Q4 25 | — | 7.6% | ||
| Q3 25 | 20.8% | 1.8% | ||
| Q2 25 | 34.8% | 2.3% | ||
| Q1 25 | 91.8% | 1.8% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | 5.3% | 1.0% |
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | -0.47× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | — | 4.83× | ||
| Q3 24 | — | 3.19× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
